Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 43INDUSTRY 26NIH 8OTHER_GOV 2NETWORK 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 2

Conditions

Breast Neoplasms 49Prostatic Neoplasms 38Carcinoma, Non-Small-Cell Lung 28Neoplasms 24Precursor Cell Lymphoblastic Leukemia-Lymphoma 23Multiple Myeloma 22Lymphoma 21Leukemia, Myeloid, Acute 17Colorectal Neoplasms 17Melanoma 15Lung Neoplasms 13Hodgkin Disease 11Brain Neoplasms 11Medulloblastoma 10Lymphoma, Non-Hodgkin 10HIV Infections 10Glioblastoma 10Squamous Cell Carcinoma of Head and Neck 9Pancreatic Neoplasms 9Neoplasm Metastasis 9Leukemia, Biphenotypic, Acute 9Leukemia 9Head and Neck Neoplasms 9Neuroblastoma 8Hematologic Neoplasms 8Ependymoma 8Glioma 7Carcinoma, Renal Cell 7Astrocytoma 7Wilms Tumor 6

Interventions

nintedanib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Mesothelioma, Malignant × 1 year × Clear all
NCT02863055 2025-09-19

NEMO

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated
37 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT02214134 2025-08-17

SPECTAlung

European Organisation for Research and Treatment of Cancer - EORTC

Completed
539 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡